PUMA BIOTECHNOLOGY, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for the quarter ending 2022-12-31 was $2.43M.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was -$53.00K.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $1.00K.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for the quarter ending 2022-03-31 was $9.85M.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for fiscal 2022 was $12.22M.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for fiscal 2016 was $161.85M, a 21.10% decline from fiscal 2015.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for fiscal 2015 was $205.13M, a 58.48% increase from fiscal 2014.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, new issues for fiscal 2014 was $129.44M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2022-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $12.22M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$53.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $9.85M 10-Q · filed 2023-05-04 | |
| 2016-12-31 | $161.85M 10-K · filed 2019-03-01 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $205.13M 10-K · filed 2018-03-09 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $205.13M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | $205.20M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $129.44M 10-K · filed 2017-03-01 |
| 2012-12-31 | $129.21M 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |